Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04195698 · COMPLETED
Trial details
- NCT number
- NCT04195698
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2023-09-11
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.